follow us:Google+ FacebookLinkedInTwitterRSS Feeds

advertisement

Celgene announces $600 million share repurchase program

By

Back to Top Comments Email Print

Latest News

    advertisement

    Summit-based life sciences company Celgene Corp. announced today it is repurchasing $600 million in shares of its common stock through an accelerated repurchase agreement with an investment bank.

    The agreement is part of an ongoing program to repurchase shares of its stock. Year to date, Celgene has repurchased approximately $385 million of its common stock, and has approximately $1.45 billion remaining in the existing program, according to a news release.

    The name of the investment bank was not disclosed.

    Share This Story On:

    Write to the Editorial Department at editorial@njbiz.com

    advertisement

    Comments


    Be the first to comment.



    Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

    Post Comment
         View Comment Policy

    Advanced search
    Sponsored by
    advertisement
      
      
    advertisement
      
      
    advertisement
    Back to Top